Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study

OBJECTIVE: To assess the real-world cardiovascular (CV) safety for sulfonylureas (SU), in comparison with dipeptidyl peptidase 4 inhibitors (DPP4i) and thiazolidinediones (TZD), through development of robust methodology for causal inference in a whole nation study. RESEARCH DESIGN AND METHODS: A coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Cordiner, Ruth L.M., Huang, Yu, Donnelly, Louise, Hapca, Simona, Collier, Andrew, McKnight, John, Kennon, Brian, Gibb, Fraser, McKeigue, Paul, Wild, Sarah H., Colhoun, Helen, Chalmers, John, Petrie, John, Sattar, Naveed, MacDonald, Thomas, McCrimmon, Rory J., Morales, Daniel R., Pearson, Ewan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154665/
https://www.ncbi.nlm.nih.gov/pubmed/36944118
http://dx.doi.org/10.2337/dc22-1238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154665/
https://www.ncbi.nlm.nih.gov/pubmed/36944118
http://dx.doi.org/10.2337/dc22-1238

Ejemplares similares